| Clear cell Basal cell carcinoma with pulmonary metastasis: case report and literature review. | |
| | |
MedLine Citation:
|
PMID: 21048492 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Clear cell basal cell carcinoma is a rare histological variant of basal cell carcinoma, which has been well described in the literature. We herein report a case of a 56-year-old man who developed lung metastasis from a rather aggressive tumor that grew very rapidly to involve the parotid gland, the mandibular bone, and even the petrous portion of the temporal bone, the middle ear, and the dura mater. Histological diagnosis was clear cell carcinoma, and initially a salivary origin was suspected. Only in the resection specimen, we found areas of more conventional basal cell carcinoma, and final diagnosis was clear cell basal cell carcinoma. We herein report a case of this rare variant and comment on the histopathological differential diagnosis and the possible relation between these tumors and Gorlin-Goltz syndrome. |
| | |
Authors:
|
M J Fernández-Aceñero; Carlos Cenjor; Sharon Córdova |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The American Journal of dermatopathology Volume: 33 ISSN: 1533-0311 ISO Abbreviation: Am J Dermatopathol Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-05-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7911005 Medline TA: Am J Dermatopathol Country: United States |
Other Details:
|
Languages: eng Pagination: 379-82 Citation Subset: IM |
Affiliation:
|
From the Departments of *Surgical Pathology; and †Otolaryngology, Fundación Jiménez Díaz (Capio Group Spain), Madrid, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparative immunohistochemical analyses on the modes of cell death/keratinization in epidermal cyst...
Next Document: New advances in targeted therapies for squamous cell carcinoma of the head and neck.